Cargando…

RNA m(6)A methylation in cancer

N (6) ‐methyladenosine (m(6)A) is one of the most abundant internal modifications in eukaryotic messenger RNAs (mRNAs) and non‐coding RNAs (ncRNAs). It is a reversible and dynamic RNA modification that has been observed in both internal coding segments and untranslated regions. Studies indicate that...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zhaotong, Zhou, Jiawang, Zhang, Haisheng, Ge, Lichen, Li, Jiexin, Wang, Hongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892831/ https://www.ncbi.nlm.nih.gov/pubmed/36260366 http://dx.doi.org/10.1002/1878-0261.13326

Ejemplares similares

RNA m(1)A methylation regulates glycolysis of cancer cells through modulating ATP5D
por: Wu, Yingmin, et al.
Publicado: (2022)

5′-tRF-GlyGCC: a tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis
por: Wu, Yingmin, et al.
Publicado: (2021)

A novel inhibitor of N(6)-methyladenosine demethylase FTO induces mRNA methylation and shows anti-cancer activities
por: Xie, Guoyou, et al.
Publicado: (2022)

N(1)-methyladenosine modification in cancer biology: Current status and future perspectives
por: Li, Jiexin, et al.
Publicado: (2022)

RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail
por: Lin, Xinyao, et al.
Publicado: (2019)

Rolling circle extension-assisted loop-mediated isothermal amplification (Rol-LAMP) method for locus-specific and visible detection of RNA N(6)-methyladenosine
por: Li, Jiexin, et al.
Publicado: (2023)

Retraction Note: RNA m(6)A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail
por: Lin, Xinyao, et al.
Publicado: (2023)

N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming
por: Chen, Zhuojia, et al.
Publicado: (2020)

N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and metabolic reprogramming: Erratum
por: Chen, Zhuojia, et al.
Publicado: (2023)

The interplay between m6A RNA methylation and noncoding RNA in cancer
por: Ma, Shuai, et al.
Publicado: (2019)

The role of m(6)A RNA methylation in human cancer
por: Chen, Xiao-Yu, et al.
Publicado: (2019)

RNA m6A methylation regulators in ovarian cancer
por: Guo, Jialu, et al.
Publicado: (2021)

Multiple functions of m(6)A RNA methylation in cancer
por: Pan, Yutian, et al.
Publicado: (2018)

The role of m6A RNA methylation in cancer metabolism
por: An, Yuanyuan, et al.
Publicado: (2022)

Emerging Roles for DNA 6mA and RNA m6A Methylation in Mammalian Genome
por: Xie, Leijie, et al.
Publicado: (2023)

The role of regulators of RNA m(6)A methylation in lung cancer
por: Zhang, Qicheng, et al.
Publicado: (2022)

The role of mRNA m(6)A methylation in the nervous system
por: Li, Jiashuo, et al.
Publicado: (2019)

YTHDC2 inhibits rat bone mesenchymal stem cells osteogenic differentiation by accelerating RUNX2 mRNA degradation via m6A methylation
por: Ma, Bo, et al.
Publicado: (2023)

The role m(6)A RNA methylation is CNS development and glioma pathogenesis
por: Pan, Ting, et al.
Publicado: (2021)

Prognostic Implication of the m(6)A RNA Methylation Regulators in Rectal Cancer
por: Chen, Yajie, et al.
Publicado: (2021)

Interaction between m6A methylation and noncoding RNA in glioma
por: Tao, Nairong, et al.
Publicado: (2022)

Aberrant expression of enzymes regulating m(6)A mRNA methylation: implication in cancer
por: Pinello, Natalia, et al.
Publicado: (2018)

Decoding m(6)A mRNA methylation by reader proteins in liver diseases
por: Sun, Lijiao, et al.
Publicado: (2023)

m(6)A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1
por: Wu, Yingmin, et al.
Publicado: (2019)

Research Progress of m(6)A RNA Methylation in Skin Diseases
por: Liu, Chang, et al.
Publicado: (2023)

The role of m6A methylation in therapy resistance in cancer
por: Zhuang, Hengzhao, et al.
Publicado: (2023)

Clinicopathological and immunological characterization of RNA m(6)A methylation regulators in ovarian cancer
por: Wang, Qingying, et al.
Publicado: (2020)

Current insights into the implications of m6A RNA methylation and autophagy interaction in human diseases
por: Chen, Xuechai, et al.
Publicado: (2021)

Reduced m(6)A mRNA methylation is correlated with the progression of human cervical cancer
por: Wang, Xiuli, et al.
Publicado: (2017)

N(6)-methyl-adenosine (m(6)A) in RNA: An Old Modification with A Novel Epigenetic Function
por: Niu, Yamei, et al.
Publicado: (2013)

Research progress concerning m(6)A methylation and cancer
por: Zhou, Yang, et al.
Publicado: (2021)

RNA Modification by m(6)A Methylation in Cardiovascular Disease
por: Chen, Jun, et al.
Publicado: (2021)

Emerging Roles of m(6)A RNA Methylation Regulators in Gynecological Cancer
por: Huang, Wanjun, et al.
Publicado: (2022)

Emerging role of m6A methylation modification in ovarian cancer
por: Chang, Lin-Lin, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) methylation in ischemia–reperfusion injury
por: Yao, Weifeng, et al.
Publicado: (2020)

Abnormality of m6A mRNA Methylation Is Involved in Alzheimer’s Disease
por: Han, Min, et al.
Publicado: (2020)

Recent advances of m(6)A methylation modification in esophageal squamous cell carcinoma
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Circulating exosomal small RNAs are promising non‐invasive diagnostic biomarkers for gastric cancer
por: Ge, Lichen, et al.
Publicado: (2020)

Cross-Talk between Oxidative Stress and m(6)A RNA Methylation in Cancer
por: Yang, Baishuang, et al.
Publicado: (2021)

FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA
por: Gan, Xiaojie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m8k6lodmli5tkl9ngspru2d1s3